印度GLP-1市场料提振药企
2026-07-20 04:21:53
据彭博社报道，印度减重药GLP-1市场正快速增长，预计将成为西普拉和雷迪博士实验室等药企的亮点。与此同时，这些公司在美国市场仍面临逆风。
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
西子洁能筹划境外发行H股并申请港上市Next article：
广汽本田经营期限延至2038年
